Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q1 2026 · 10-Q
Revenue$2.52B$2.52B+11.7% vs Q1 2025 Net Income-$1.42B-$1.42BN/M vs Q1 2025 EPS Diluted-$3.82-$3.82N/M vs Q1 2025 Operating Income-$950,000,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Free Cash Flowderived$121,000,000+26.0% Margins · derivedOperating margin-37.6%−49.9 pt vs Q1 2025
Net margin-56.4%−53.8 pt vs Q1 2025
ended Mar 31, 2026 · filed Apr 30, 2026 · 30 d after period end